Zydus Lifesciences share price extended the gains on third consecutive session on March 19, rising more than 1 percent after company received final approval from USFDA for Apalutamide Tablets, 60 ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...
Eurogrip Tyres, India's leading 2 & 3-wheeler tyre brand, has launched a new brand campaign that brings together MS Dhoni's ...
Atishay Ltd has secured a significant new work order from The Udaipur Central Cooperative Bank Ltd., Udaipur, Rajasthan.
Prudent’s stock has plummeted more than 40% from its peak price Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol ...
CEOs, CIOs, CTOs Hospitals, healthcare companies pharma companies, Health tech providers, healthcare start-ups ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Nippon India Small Cap Fund (B) 467.76 29,95,942 0.92 Nippon India Small Cap Fund (IDCW) 467.76 29,95,942 0.92 Nippon India Small Cap Fund (G) 467.76 29,95,942 0.92 ...
Zydus Lifesciences Ltd. is a Public Limited Listed company incorporated on 15/05/1995 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is ...
Zydus Wellness Ltd., incorporated in the year 1994, is a Mid Cap company (having a market cap of Rs 10,611.30 Crore) operating in FMCG sector. Zydus Wellness Ltd. key Products/Revenue Segments include ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.